Skip to main content

Table 3 Prevalence of MetS components according to the Interim consensus (IDF-C) or the modified NCEP ATP III (ATP III-M) criteria

From: Prevalence of metabolic syndrome among urban community residents in China

 

IDF-Ca[n(%)]

ATP III-Mb[n(%)]

No. of Criteria met

DM and CHD included

DM and CHD excluded

DM and CHD included

DM and CHD excluded

Met 5 criteria

686(3.1)

382(2.0)

198(0.9)

77(0.4)

Met 4 criteria

2318(10.3)

1667(8.6)

1328(5.9)

797(4.1)

Met 3 criteria

4518(20.1)

3497(18.1)

3824(17.0)

2761(14.3)

Met 2 criteria

5776(25.7)

5014(26.0)

5953(26.5)

5059(26.2)

Met 1 criteria

5386(24.0)

5026(26.1)

6502(29.0)

6031(31.3)

Met 0 criteria

3773(16.8)

3698(19.2)

4652(20.7)

4559(23.7)

total

22457

19284

22457

19284

  1. a IDF-C (joint interim consensus criteria by IDF and other organization): Diabetes or fasting glucose ≥ 100 mg/dL; Hypertension or SBP ≥ 130 mmHg or DBP ≥ 85 mmHg; Dyslipidemia or HDL < 40 mg/dL for men and HDL < 50 mg/dL for women; Dyslipidemia or Triglycerides ≥ 150 mg/dL; Waist circumference ≥ 85 cm for men and ≥ 80 cm for women.
  2. b ATP III-M (modified NCEP ATP III criteria): Diabetes or fasting glucose ≥ 110 mg/dL; Hypertension or SBP ≥ 130 mmHg or DBP ≥ 85mmHg; Dyslipidemia or HDL < 40 mg/dL for both men and women; Dyslipidemia or Triglycerides ≥ 150 mg/dL; Waist circumference ≥ 90cm for men and ≥ 80 cm for women.